-
The debate continues as to whether coronary artery bypass graft (CABG) surgery with left-internal mammary artery (LIMA) or stenting is the best treatment for proximal left-anterior descending coronary artery (LAD) lesions.
-
This report from the Framingham heart study looks at the prognostic significance of PR interval prolongation in ambulatory, relatively healthy individuals.
-
Functional mitral regurgitation (FMR), occurring in heart failure, portends an adverse prognosis.
-
Pulmonary arterial hypertension (PAH) is a dreaded multifactorial disease that is usually fatal. PAH can be a result of a number of conditions, including chronic thromboembolic hypertension, HIV, and congenital cardiac lessons, such as a large ASD with pulmonary shunting resulting in decreased nitric oxide (NO) expression.
-
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
-
Primary percutaneous coronary intervention (PCI) results in more complete reperfusion of the infarct artery and lower rates of re-occlusion than fibrinolysis in patients with ST elevation myocardial infarction (STEMI). However, primary PCI is not performed at all centers, and fibrinolysis is still in widespread use.
-
Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
-
This paper describes the results of an epidemiologic survey of the results of in-hospital cardiopulmonary resuscitation (CPR) in U.S. hospitals. Ehlenbach et al analyzed the Medicare Provider Analysis and Review (MedPAR) hospital claims database for the years from 1992-2005 and identified Medicare beneficiaries for whom a claim for in-hospital CPR had been made.
-
After the JUPITER trial showed that individuals with LDL cholesterols < 130 mg/dL, but high sensitivity CRP > 2.0 benefited from statin therapy, there has been considerable interest in using biomarkers for individualizing treatment.